The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukopenia


Psychiatry related information on Leukopenia


High impact information on Leukopenia


Chemical compound and disease context of Leukopenia


Biological context of Leukopenia


Anatomical context of Leukopenia

  • To determine whether invading leukocytes mediate these responses, acute inflammatory cell influx was suppressed either by inducing leukopenia with nitrogen mustard or by administration of BW-755C, a mixed cyclooxygenase-lipoxygenase inhibitor [23].
  • We have engineered transgenic mice that express this multidrug transporter in their bone marrow and demonstrated that these animals are resistant to leukopenia by a panel of anticancer drugs including anthracyclines, vinca alkaloids, etoposide, taxol, and actinomycin D [24].
  • LPS-induced pulmonary vascular injury was significantly attenuated in rats with nitrogen mustard-induced leukocytopenia and in rats treated with ONO-5046, a potent granulocyte elastase inhibitor [25].
  • The induction of leukocytopenia had the same effect as APC, in that it significantly reduced motor disturbances, tissue levels of TNF-alpha, and neutrophil accumulation in the animals subjected to compressive SCI [26].
  • Potential risk factors included RA severity measures (rheumatoid factor positivity, elevated erythrocyte sedimentation rate, extraarticular manifestations of RA, and functional status), comorbidities (diabetes mellitus, alcoholism, and chronic lung disease), and other risk factors for infection (presence of leukopenia, smoking) [27].

Gene context of Leukopenia


Analytical, diagnostic and therapeutic context of Leukopenia

  • CONCLUSIONS: This dose-intensive regimen can be given safely without progenitor replacement. rhu GM-CSF decreases the duration of severe leukopenia and decreases the need for hospitalization and antibiotic therapy [33].
  • Hemodialysis of 11 endstage renal failure patients with new cuprophan hollow fiber dialyzers produced significant leukopenia as well as increased plasma levels of both C3a and C5a antigens during the initial phases of the procedure [34].
  • CONCLUSIONS: NM conditioning with posttransplant immunosuppression using CsA and MMF resulted in less leukopenia and fewer transfusions, but resulted in more cases of graft failure, acute GVHD, and TRM than in RIC patients [35].
  • BACKGROUND: Our study assessed the factors that predispose renal transplant recipients to the occurrence of thrombocytopenia and leukopenia, as well as the severity and the time- and concentration-dependence of these side-effects, after administration of sirolimus (SRL) in combination with a cyclosporine (CsA) and prednisone (Pred) regimen [36].
  • The polysaccharide showed no indications of toxicity in mice at doses far in excess of the lethal dose for the parent glycolipoprotein, nor did the mice develop the leukopenia that characteristically follows intraperitoneal injection of glycolipoprotein [37].


  1. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Mozes, E., Kohn, L.D., Hakim, F., Singer, D.S. Science (1993) [Pubmed]
  2. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. Vasily, D.B., Tyler, W.B. JAMA (1980) [Pubmed]
  3. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. Okusawa, S., Gelfand, J.A., Ikejima, T., Connolly, R.J., Dinarello, C.A. J. Clin. Invest. (1988) [Pubmed]
  4. Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. Calabresi, P., Falcone, A., St Clair, M.H., Wiemann, M.C., Chu, S.H., Darnowski, J.W. Blood (1990) [Pubmed]
  5. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Rabinovici, R., Esser, K.M., Lysko, P.G., Yue, T.L., Griswold, D.E., Hillegass, L.M., Bugelski, P.J., Hallenbeck, J.M., Feuerstein, G. Circ. Res. (1991) [Pubmed]
  6. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Mendlovic, S., Fricke, H., Shoenfeld, Y., Mozes, E. Eur. J. Immunol. (1989) [Pubmed]
  7. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation. Lindholm, A., Albrechtsen, D., Tufveson, G., Karlberg, I., Persson, N.H., Groth, C.G. Transplantation (1992) [Pubmed]
  8. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy, W.D., Feinberg, J., Finkelstein, D.M., Power, M.E., He, W., Kaczka, C., Frame, P.T., Holmes, M., Waskin, H., Fass, R.J. N. Engl. J. Med. (1992) [Pubmed]
  9. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. Allo, M.D., Miller, J., Townsend, T., Tan, C. N. Engl. J. Med. (1987) [Pubmed]
  10. The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. Lyman, G.H., Williams, C.C., Preston, D. N. Engl. J. Med. (1980) [Pubmed]
  11. Pediatric ibuprofen and leukopenia. Lesko, S.M., Mitchell, A.A. JAMA (1996) [Pubmed]
  12. Computerized surveillance of adverse drug events in hospital patients. Classen, D.C., Pestotnik, S.L., Evans, R.S., Burke, J.P. JAMA (1991) [Pubmed]
  13. Leukopenia secondary to sulfadiazine silver. Fraser, G.L., Beaulieu, J.T. JAMA (1979) [Pubmed]
  14. Minocycline treatment of pulmonary nocardiosis. Petersen, E.A., Nash, M.L., Mammana, R.B., Copeland, J.G. JAMA (1983) [Pubmed]
  15. Leukopenia following treatment with thiothixene and haloperidol. Cutler, N.R., Heiser, J.F. JAMA (1979) [Pubmed]
  16. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer. Hansen, R.M., Ryan, L., Anderson, T., Krzywda, B., Quebbeman, E., Benson, A., Haller, D.G., Tormey, D.C. J. Natl. Cancer Inst. (1996) [Pubmed]
  17. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. Pollack, M., Young, L.S. J. Clin. Invest. (1979) [Pubmed]
  18. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. Jodrell, D.I., Egorin, M.J., Canetta, R.M., Langenberg, P., Goldbloom, E.P., Burroughs, J.N., Goodlow, J.L., Tan, S., Wiltshaw, E. J. Clin. Oncol. (1992) [Pubmed]
  19. Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Singh, N., Yu, V.L., Mieles, L.A., Wagener, M.M. Am. J. Med. (1993) [Pubmed]
  20. Supplemental vitamin A prevents the acute radiation-induced defect in wound healing. Levenson, S.M., Gruber, C.A., Rettura, G., Gruber, D.K., Demetriou, A.A., Seifter, E. Ann. Surg. (1984) [Pubmed]
  21. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Chenoweth, D.E., Cheung, A.K., Henderson, L.W. Kidney Int. (1983) [Pubmed]
  22. Increased severity of urinary tract infection and bacteremia in mice with urinary bladder injury induced by cyclophosphamide. Lyon, D., Howard, E.B., Montgomerie, J.Z. Infect. Immun. (1982) [Pubmed]
  23. Role of invading leukocytes in enhanced atrial eicosanoid production following rabbit left ventricular myocardial infarction. Freed, M.S., Needleman, P., Dunkel, C.G., Saffitz, J.E., Evers, A.S. J. Clin. Invest. (1989) [Pubmed]
  24. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Mickisch, G.H., Merlino, G.T., Galski, H., Gottesman, M.M., Pastan, I. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  25. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Murakami, K., Okajima, K., Uchiba, M., Johno, M., Nakagaki, T., Okabe, H., Takatsuki, K. Blood (1996) [Pubmed]
  26. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Harada, N., Johno, M., Naruo, M. J. Neurosci. (1998) [Pubmed]
  27. Predictors of infection in rheumatoid arthritis. Doran, M.F., Crowson, C.S., Pond, G.R., O'Fallon, W.M., Gabriel, S.E. Arthritis Rheum. (2002) [Pubmed]
  28. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri, S., Leonardi, V., Danova, M., Porta, C., Ferrari, S., Fincato, G., Citarrella, P. Haematologica (1999) [Pubmed]
  29. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Kurzawski, M., Dziewanowski, K., Gawrońska-Szklarz, B., Domański, L., Droździk, M. Therapeutic drug monitoring. (2005) [Pubmed]
  30. Management of early renal anaemia: diagnostic work-up, iron therapy, epoetin therapy. Van Wyck, D.B. Nephrol. Dial. Transplant. (2000) [Pubmed]
  31. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Storek, J., Zhao, Z., Lin, E., Berger, T., McSweeney, P.A., Nash, R.A., Akatsuka, Y., Metcalf, M.D., Lu, H., Kalina, T., Reindl, M., Storb, R., Hansen, J.A., Sullivan, K.M., Kraft, G.H., Furst, D.E., Maloney, D.G. Clin. Immunol. (2004) [Pubmed]
  32. Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients. Oude Nijhuis, C.S., Vellenga, E., Daenen, S.M., Kamps, W.A., De Bont, E.S. Clin. Diagn. Lab. Immunol. (2003) [Pubmed]
  33. Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy. Neidhart, J.A., Mangalik, A., Stidley, C.A., Tebich, S.L., Sarmiento, L.E., Pfile, J.E., Oette, D.H., Oldham, F.B. J. Clin. Oncol. (1992) [Pubmed]
  34. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers. Chenoweth, D.E., Cheung, A.K., Ward, D.M., Henderson, L.W. Kidney Int. (1983) [Pubmed]
  35. A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Le Blanc, K., Remberger, M., Uzunel, M., Mattsson, J., Barkholt, L., Ringdén, O. Transplantation (2004) [Pubmed]
  36. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. Hong, J.C., Kahan, B.D. Transplantation (2000) [Pubmed]
  37. Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa. Koepp, L.H., Orr, T., Bartell, P.F. Infect. Immun. (1981) [Pubmed]
WikiGenes - Universities